A systematic approach is described for building validated PLS models that predict cholesterol and triglyceride concentrations in lipoprotein subclasses in fasting serum from a normolipidemic, healthy population. The PLS models were built on diffusion-edited (1)H NMR spectra and calibrated on HPLC-derived lipoprotein subclasses. The PLS models were validated using an independent test set. In addition to total VLDL, LDL, and HDL lipoproteins, statistically significant PLS models were obtained for 13 subclasses, including 5 VLDLs (particle size 64-31.3 nm), 4 LDLs (particle size 28.6-20.7 nm) and 4 HDLs (particle size 13.5-9.8 nm). The best models were obtained for triglycerides in VLDL (0.82 <Q(2
The lipid composition of lipoprotein particles is determinative of their respective formation and fu...
Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) a...
Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) a...
A systematic approach is described for building validated PLS models that predict cholesterol and tr...
A systematic approach is described for building validated PLS models that predict cholesterol and tr...
A systematic approach is described for building validated PLS models that predict cholesterol and tr...
Lipoprotein subfractions are biomarkers for the early diagnosis of cardiovascular diseases. The refe...
Lipoprotein profiling of human blood by 1H nuclear magnetic resonance (NMR) spectroscopy is a rapid ...
This study represents the first application of multi-way calibration by N-PLS and multi-way curve re...
Lipoproteins are a wide class of biological structures represented by micellar aggregates of biomole...
We report an extensive 600 MHz NMR trial of quantitative lipoprotein and small-molecule measurements...
NMR-based quantification of human lipoprotein (sub)classes is a powerful high-throughput method for ...
Determination of lipoprotein particle size and number using advanced lipoprotein tests (ALTs) is of ...
Determination of lipoprotein particle size and number using advanced lipoprotein tests (ALTs) is of ...
Liposcale: A novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopyDeterm...
The lipid composition of lipoprotein particles is determinative of their respective formation and fu...
Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) a...
Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) a...
A systematic approach is described for building validated PLS models that predict cholesterol and tr...
A systematic approach is described for building validated PLS models that predict cholesterol and tr...
A systematic approach is described for building validated PLS models that predict cholesterol and tr...
Lipoprotein subfractions are biomarkers for the early diagnosis of cardiovascular diseases. The refe...
Lipoprotein profiling of human blood by 1H nuclear magnetic resonance (NMR) spectroscopy is a rapid ...
This study represents the first application of multi-way calibration by N-PLS and multi-way curve re...
Lipoproteins are a wide class of biological structures represented by micellar aggregates of biomole...
We report an extensive 600 MHz NMR trial of quantitative lipoprotein and small-molecule measurements...
NMR-based quantification of human lipoprotein (sub)classes is a powerful high-throughput method for ...
Determination of lipoprotein particle size and number using advanced lipoprotein tests (ALTs) is of ...
Determination of lipoprotein particle size and number using advanced lipoprotein tests (ALTs) is of ...
Liposcale: A novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopyDeterm...
The lipid composition of lipoprotein particles is determinative of their respective formation and fu...
Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) a...
Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) a...